T. Rinda Soong, MD, PhD, MPH
Assistant Professor of Pathology

Dr. Parks

Dr. Soong is a member of the Division of Gynecologic and Breast Pathology.

Office Location:
Rm. 4428
Magee-Womens Hospital
300 Halket Street
Pittsburgh, PA 15213
Contact Information:
Office Telephone: 412-641-3347
Office Fax: 412-641-1675
Email: soongt@upmc.edu

Education

  • MD - Johns Hopkins University School of Medicine, 2011
  • MPH - Johns Hopkins Bloomberg School of Public Health, 2009
  • PhD - Johns Hopkins Bloomberg School of Public Health, 2015

Training

  • Residency, Anatomic and Clinical Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 2011-2016
  • Fellowship, Women's and Perinatal Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 2016-2017
  • Fellowship, Surgical Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 2017-2018

Clinical Expertise

  • Gynecologic Pathology
  • Breast Pathology

Certification

    Anatomic and Clinical Pathology, American Board of Pathology

Selected Awards and Honors

  • Scientific Scholar Award, Rivkin Center for Ovarian Cancer Research, 2020
  • Building Bridges Research Award, University of Washington, 2019
  • The Harvey M. Meyerhoff Fellowship Award in Cancer Prevention, Johns Hopkins Bloomberg School of Public Health, 2011

Research Interests:

Dr. Soong's research interests focus on the pathogenesis, detection and prevention of women's cancers, in particular the following areas:
  • Pathogenesis of pelvic high-grade serous carcinoma in association with host exposures and risk factors in local microenvironment.
  • Molecular-epidemiologic-pathologic profiles in the development and progression of gynecologic cancer and breast cancer.
  • Premalignant biology of ovarian cancer and cervical cancer.

Selected Publications

View Dr. Soong's research publications https://pubmed.ncbi.nlm.nih.gov/?term=soong+TR on Pubmed

  • Soong TR, Howitt BH, Horowitz N, Nucci MR, Crum CP. The fallopian tube, "precursor escape" and narrowing the gap to the origins of high-grade serous carcinoma. Gynecol Oncol. 2019; 152(2):426-433.
  • Harrison BT, Nakhlis F, Dillon DA, Soong TR, Garcia EP, Schnitt SJ, King TA. Genomic profiling of pleomorphic and florid lobular carcinoma in situ reveals highly recurrent ERBB2 and ERRB3 alterations. Mod Pathol. 2020 Jan 13 [Epub ahead of print].
  • Soong TR, Howitt BE, Miron A, Horowitz NS, Campbell F, Feltmate CM, Muto MG, Berkowitz RS, Nucci MR, Xian W, Crum CP. Evidence for lineage continuity between early serous proliferations (ESPs) in the Fallopian tube and disseminated high-grade serous carcinomas. J Pathol. 2018; 246(3):344-351.
  • Soong TR, Dinulescu DM, Xian W, Crum CP. Frontiers in the Pathology and Pathogenesis of Ovarian cancer: Cancer Precursors and "Precursor Escape". Hematol Oncol Clin N Am. 2018; 32(6):915-928.
  • Soong TR, Kolin DL, Teschan NJ, Crum CP. Back to the Future? The Fallopian Tube, Precursor Escape and a Dualistic Model of High-Grade Serous Carcinogenesis Cancers (Basel). 2018; 10(12). pii: E468.
  • Mallen A*, Soong TR*, Townsend M, Wenham R, Crum CP, Tworoger SS. Surgical prevention strategies in ovarian cancer. Gynecol Oncol. 2018; 151(1):166-175. (*Contributed equally as co-first authors.)
  • Soong TR*, Davis M*, Yuan L, Elias K, Horowitz N, Goldstein D, Berkowitz R, Quade BJ. Clinical outcomes of partial hydatidiform moles in the post-p57 era. J Reprod Med. 2018; 63:199-208. (*Contributed equally as co-first authors.)
  • Meserve EE, Strickland KC, Miron A, Soong TR, Campbell F, Howitt BE, Crum CP. Evidence of a monoclonal origin for bilateral serous tubal intraepithelial neoplasia. Int J Gynecol Pathol. 2019; 38(5):443-448.
  • Soong TR , Nayor J, Stachler M, Perencevich M, Jajoo K, Saltzman J, Lindeman NI, Srivastava A. Clinicopathologic and genetic characteristics of interval colorectal carcinomas favor origin from missed or incompletely excised precursors. Mod Pathol. 2019; 32(5):666-674.
  • Hamada T*, Soong TR*, Masugi Y*, Kosumi K*, Nowak JA, da Silva A, et al. TIME (Tumor Immunity in the MicroEnvironment) classification based on tumor CD274 (PD-L1) expression status and tumor-infiltrating lymphocytes in colorectal carcinomas. Oncoimmunology. 2018; 19; 7(7):e1442999. (*Contributed equally as co-first authors.)
  • Herfs M, Soong TR, Delvenne P, Crum CP. Deciphering the multifactorial susceptibility of mucosal junction cells to HPV infection and related carcinogenesis. Viruses. 2017; 20; 9(4).